Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Low rates of clinical recurrence after biopsy of benign to moderately dysplastic melanocytic nevi.

Goodson AG, Florell SR, Boucher KM, Grossman D.

J Am Acad Dermatol. 2010 Apr;62(4):591-6. doi: 10.1016/j.jaad.2009.06.080. Epub 2009 Dec 16.

2.

Low clinically significant rate of recurrence in benign nevi.

Tallon B, Snow J.

Am J Dermatopathol. 2012 Oct;34(7):706-9.

PMID:
22421296
3.

The utility of re-excising mildly and moderately dysplastic nevi: a retrospective analysis.

Strazzula L, Vedak P, Hoang MP, Sober A, Tsao H, Kroshinsky D.

J Am Acad Dermatol. 2014 Dec;71(6):1071-6. doi: 10.1016/j.jaad.2014.08.025. Epub 2014 Sep 26.

PMID:
25262175
4.

Recurrent dysplastic nevus following shave excision.

Duray PH, Livolsi VA.

J Dermatol Surg Oncol. 1984 Oct;10(10):811-5.

PMID:
6491020
5.

Reexamining the Threshold for Reexcision of Histologically Transected Dysplastic Nevi.

Fleming NH, Egbert BM, Kim J, Swetter SM.

JAMA Dermatol. 2016 Dec 1;152(12):1327-1334. doi: 10.1001/jamadermatol.2016.2869.

PMID:
27542070
6.

Recurrence of moderately dysplastic nevi with positive histologic margins.

Hiscox B, Hardin MR, Orengo IF, Rosen T, Mir M, Diwan AH.

J Am Acad Dermatol. 2017 Mar;76(3):527-530. doi: 10.1016/j.jaad.2016.09.009. Epub 2016 Dec 24.

PMID:
28027827
7.

To scoop or not to scoop: the diagnostic and therapeutic utility of the scoop-shave biopsy for pigmented lesions.

Mendese G, Maloney M, Bordeaux J.

Dermatol Surg. 2014 Oct;40(10):1077-83. doi: 10.1097/01.DSS.0000452659.60130.68.

PMID:
25229784
8.

Deep shave excision of macular melanocytic nevi with the razor blade biopsy technique.

Gambichler T, Senger E, Rapp S, Alamouti D, Altmeyer P, Hoffmann K.

Dermatol Surg. 2000 Jul;26(7):662-6.

PMID:
10886275
9.

Pseudomelanoma following laser therapy for congenital nevus.

Trau H, Orenstein A, Schewach-Miller M, Tsur H.

J Dermatol Surg Oncol. 1986 Sep;12(9):984-6.

PMID:
3745625
10.

Clinical diagnosis of dysplastic melanocytic nevi. A clinicopathologic correlation.

Kelly JW, Crutcher WA, Sagebiel RW.

J Am Acad Dermatol. 1986 Jun;14(6):1044-52.

PMID:
3722481
11.

A prospective study evaluating the utility of a 2-mm biopsy margin for complete removal of histologically atypical (dysplastic) nevi.

Terushkin V, Ng E, Stein JA, Katz S, Cohen DE, Meehan S, Polsky D.

J Am Acad Dermatol. 2017 Dec;77(6):1096-1099. doi: 10.1016/j.jaad.2017.07.016. Epub 2017 Oct 2.

PMID:
28982585
12.

Melanocytic nevi, dysplastic nevi, and malignant melanoma in children from melanoma-prone families.

Novakovic B, Clark WH Jr, Fears TR, Fraser MC, Tucker MA.

J Am Acad Dermatol. 1995 Oct;33(4):631-6.

PMID:
7673498
13.

Margin comments in dermatopathology reports on dysplastic nevi influence re-excision rates.

Comfere NI, Chakraborty R, Peters MS.

J Am Acad Dermatol. 2013 Nov;69(5):687-92. doi: 10.1016/j.jaad.2013.06.026. Epub 2013 Aug 6.

PMID:
23932648
14.

The role of observation in the management of atypical nevi.

Kmetz EC, Sanders H, Fisher G, Lang PG, Maize JC Sr.

South Med J. 2009 Jan;102(1):45-8. doi: 10.1097/SMJ.0b013e3181904289.

PMID:
19077745
15.

A retrospective look at dysplastic nevi. What were they in 1978 and how have they fared since?

Cockerell CJ, Berson DS.

Am J Dermatopathol. 1985;7 Suppl:93-7.

PMID:
3940095
16.

[Shave excision of melanocytic nevi of the skin: indications, technique, results].

Breuninger H, Garbe C, Rassner G.

Hautarzt. 2000 Aug;51(8):575-80. German.

PMID:
10997312
17.

Prediction of histologic melanocytic dysplasia from clinical observation.

Roush GC, Dubin N, Barnhill RL.

J Am Acad Dermatol. 1993 Oct;29(4):555-62.

PMID:
8408790
18.

The recurrent nevus phenomenon.

Castagna RD, Stramari JM, Chemello RML.

An Bras Dermatol. 2017 Jul-Aug;92(4):531-533. doi: 10.1590/abd1806-4841.20176190.

19.

Dysplastic (or Atypical) Nevi Showing Moderate or Severe Atypia With Clear Margins on the Shave Removal Specimens Are Most Likely Completely Excised.

Maghari A.

J Cutan Med Surg. 2017 Jan/Feb;21(1):42-47. doi: 10.1177/1203475416661313. Epub 2016 Jul 21.

PMID:
27436823
20.

Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma?

Skender-Kalnenas TM, English DR, Heenan PJ.

J Am Acad Dermatol. 1995 Dec;33(6):1000-7.

PMID:
7490345

Supplemental Content

Support Center